Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States
- PMID: 29199144
- PMCID: PMC6467713
- DOI: 10.1016/j.cgh.2017.11.045
Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States
Conflict of interest statement
Conflicts of interest
The authors disclose no conflicts.
Figures
References
-
- Cholankeril G, Li AA, March KL, et al. Improved outcomes in HCV patients following liver transplantation during the era of direct acting antiviral agents. Clin Gastroenterol Hepatol 2018; 16:452–453. - PubMed
-
- Barua S, Greenwald R, Grebely J, et al. Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States. Ann Intern Med 2015; 163:215–223. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
